Studio in vitro: stress ossidativo e senescenza cellulare in cartilagine e sinovia da diverse sedi anatomiche. Studio comparativo su differenti patologie articolari (OA e AR)

Title

Code

AROA tissue damage

Type

In Vitro

Start Year

2022

Status

In Corso

Principal Investigator

051-6366386

francesco.ursini@ior.it

Prof. Ursini Francesco

Medicine and Rheumatology

Operational unit that carry out the study

departmental simple unit

Medicina e reumatologia

Temporary Head

Faldini Cesare, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio clinico prot. AROA tissue damage

Thursday 14 July 2022, 17:17

PG0010977_2022_prot. AROA.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Studio in vitro: stress ossidativo e senescenza cellulare in cartilagine e sinovia da diverse sedi anatomiche. Studio comparativo su differenti patologie articolari (OA e AR)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Studio in vitro: stress ossidativo e senescenza cellulare in cartilagine e sinovia da diverse sedi anatomiche. Studio comparativo su differenti patologie articolari (OA e AR)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in